-
Jul 6, 2007
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aug. 6, 2007--Curis, Inc. (NASDAQ:CRIS), a drug development company focused on seeking to develop novel targeted medicines primarily for cancer treatment, today...
-
May 18, 2007Ortho Biotech Products, L.P. Terminates License;
CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 18, 2007--Curis, Inc. (NASDAQ: CRIS), a drug development company focused on seeking to develop novel targeted medicines primarily for cancer treatment, today...
-
May 11, 2007
CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 11, 2007--Curis, Inc. (NASDAQ: CRIS), a drug development company focused on developing novel targeted medicines primarily for cancer treatment, today...
-
May 10, 2007
CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 10, 2007--Curis, Inc. (NASDAQ: CRIS), a drug development company focused on developing novel targeted medicines primarily for cancer treatment, today...
-
May 9, 2007
CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 9, 2007--Curis, Inc. (NASDAQ: CRIS), a drug development company focused on developing novel targeted medicines primarily for cancer treatment, today provided...